| Product Code: ETC6749317 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Ophthalmology Drugs and Devices Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Ophthalmology Drugs and Devices Market Revenues & Volume, 2021 & 2031F |
3.3 China Ophthalmology Drugs and Devices Market - Industry Life Cycle |
3.4 China Ophthalmology Drugs and Devices Market - Porter's Five Forces |
3.5 China Ophthalmology Drugs and Devices Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.6 China Ophthalmology Drugs and Devices Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 China Ophthalmology Drugs and Devices Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 China Ophthalmology Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye diseases and disorders in China |
4.2.2 Growing elderly population in China leading to higher demand for ophthalmology drugs and devices |
4.2.3 Technological advancements in ophthalmic treatments and devices |
4.2.4 Rising healthcare expenditure and improving healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for ophthalmology drugs and devices in China |
4.3.2 High cost associated with advanced ophthalmology drugs and devices |
4.3.3 Competition from generic products and alternative treatment options |
5 China Ophthalmology Drugs and Devices Market Trends |
6 China Ophthalmology Drugs and Devices Market, By Types |
6.1 China Ophthalmology Drugs and Devices Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Diagnostic and Monitoring Devices, 2021- 2031F |
6.1.4 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Surgical Devices, 2021- 2031F |
6.1.5 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Vision Care, 2021- 2031F |
6.1.6 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2 China Ophthalmology Drugs and Devices Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Glaucoma, 2021- 2031F |
6.2.3 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Retinal disorders, 2021- 2031F |
6.2.4 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Dry eye, 2021- 2031F |
6.2.5 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Allergy/Inflammation/Conjunctivitis, 2021- 2031F |
6.3 China Ophthalmology Drugs and Devices Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 China Ophthalmology Drugs and Devices Market Revenues & Volume, By Others, 2021- 2031F |
7 China Ophthalmology Drugs and Devices Market Import-Export Trade Statistics |
7.1 China Ophthalmology Drugs and Devices Market Export to Major Countries |
7.2 China Ophthalmology Drugs and Devices Market Imports from Major Countries |
8 China Ophthalmology Drugs and Devices Market Key Performance Indicators |
8.1 Adoption rate of advanced ophthalmology drugs and devices in China |
8.2 Number of research and development collaborations in the ophthalmology sector in China |
8.3 Rate of reimbursement for ophthalmology treatments by healthcare insurance providers in China |
9 China Ophthalmology Drugs and Devices Market - Opportunity Assessment |
9.1 China Ophthalmology Drugs and Devices Market Opportunity Assessment, By Products, 2021 & 2031F |
9.2 China Ophthalmology Drugs and Devices Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 China Ophthalmology Drugs and Devices Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 China Ophthalmology Drugs and Devices Market - Competitive Landscape |
10.1 China Ophthalmology Drugs and Devices Market Revenue Share, By Companies, 2024 |
10.2 China Ophthalmology Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here